Literature DB >> 15894459

Failed surgery for temporal lobe epilepsy: predictors of long-term seizure-free course.

J Janszky1, H W Pannek, I Janszky, R Schulz, F Behne, M Hoppe, A Ebner.   

Abstract

OBJECTIVES: To identify prognostic factors which predict the outcome 2 years after TLE surgery in those patients who were not seizure-free at the 6-month postoperative examination.
METHODS: We included 86 postoperative TLE patients who had undergone presurgical evaluation, including video-EEG and high-resolution MRI, and who had seizures between the second and sixth postoperative months.
RESULTS: 32% of patients were seizure-free in the second postoperative year. We found that normal MRI findings and secondarily generalized seizures (SGTCS) preoperatively were associated with a non-seizure-free outcome, while rare postoperative seizures and ipsilateral temporal IED with seizure-free outcome. Newly administered levetiracetam showed a significant positive effect on the postoperative outcome independent of other prognostic factors. Five of seven patients who received levetiracetam became seizure-free (p = 0.006).
CONCLUSION: One-third of patients who did not become seizure-free immediately after surgery, eventually achieved long-term seizure freedom. We suggest watching for long-term seizure freedom after failed epilepsy surgery especially in patients who had rare postoperative seizures, focal MRI abnormality, ipsilateral temporal spikes, or no SGTCS preoperatively. Levetiracetam may have a positive effect on postsurgical seizures.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15894459     DOI: 10.1016/j.eplepsyres.2005.02.004

Source DB:  PubMed          Journal:  Epilepsy Res        ISSN: 0920-1211            Impact factor:   3.045


  9 in total

1.  Stereotactic electroencephalography with temporal grid and mesial temporal depth electrode coverage: does technique of depth electrode placement affect outcome?

Authors:  Jamie J Van Gompel; Fredric B Meyer; W Richard Marsh; Kendall H Lee; Gregory A Worrell
Journal:  J Neurosurg       Date:  2010-07       Impact factor: 5.115

Review 2.  Benefit-risk assessment of levetiracetam in the treatment of partial seizures.

Authors:  Bassel Abou-Khalil
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

Review 3.  Potential of levetiracetam in mood disorders: a preliminary review.

Authors:  Anjana Muralidharan; Zubin Bhagwagar
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

4.  Temporal lobe epilepsy surgery failures: a review.

Authors:  Adil Harroud; Alain Bouthillier; Alexander G Weil; Dang Khoa Nguyen
Journal:  Epilepsy Res Treat       Date:  2012-04-22

5.  Identification of pre-spike network in patients with mesial temporal lobe epilepsy.

Authors:  Nahla L Faizo; Hana Burianová; Marcus Gray; Julia Hocking; Graham Galloway; David Reutens
Journal:  Front Neurol       Date:  2014-10-28       Impact factor: 4.003

6.  Temporal plus epilepsy: Anatomo-electroclinical subtypes.

Authors:  René Andrade-Machado; Vanessa Benjumea-Cuartas
Journal:  Iran J Neurol       Date:  2016-07-06

7.  Prognostic value of ictal onset patterns in postsurgical outcome of temporal lobe epilepsy.

Authors:  Jafar Mehvari-Habibabadi; Reza Basiratnia; Houshang Moein; Mohamad Zare; Majid Barakatain; Yahya Aghakhani; Nasim Tabrizi
Journal:  Iran J Neurol       Date:  2017-10-07

8.  Levetiracetam in the treatment of epilepsy.

Authors:  Bassel Abou-Khalil
Journal:  Neuropsychiatr Dis Treat       Date:  2008-06       Impact factor: 2.570

Review 9.  Identification of common predictors of surgical outcomes for epilepsy surgery.

Authors:  Jing Zhang; Weifang Liu; Hui Chen; Hong Xia; Zhen Zhou; Shanshan Mei; Qingzhu Liu; Yunlin Li
Journal:  Neuropsychiatr Dis Treat       Date:  2013-11-06       Impact factor: 2.570

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.